Xtl Biopharmaceuticals (XTLB) Change in Receivables (2009 - 2016)
Xtl Biopharmaceuticals (XTLB) posted quarterly Change in Receivables of -$1000.0 for Q2 2016, down 101.92% year-on-year from $52000.0 in Q3 2015, and down 103.03% on a QoQ basis from $33000.0 in Q4 2015.
Xtl Biopharmaceuticals (XTLB) Change in Receivables (2009 - 2016) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Change in Receivables for 6 consecutive years, with -$1000.0 the latest figure, recorded in Q2 2016.
- Quarterly Change in Receivables fell 101.92% year-over-year to -$1000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was -$23000.0 (down 123.23% YoY) and the FY2025 annual result came in at $157000.0, up 302.56% from the prior year.
- Change in Receivables fell to -$1000.0 in Q2 2016 per XTLB's latest filing, from $33000.0 in the prior quarter.
- Over the last five years, Change in Receivables for XTLB reached as high as $66000.0 in Q4 2014 and fell as low as -$107000.0 in Q3 2015.
- A 4-year average of -$1250.0 and a median of $500.0 in 2013 frame the typical range for Change in Receivables.
- The largest YoY upside for Change in Receivables was 430.0% in 2014 against a maximum downside of 1550.0% in 2014.
- Year by year, Change in Receivables stood at -$20000.0 in 2013, then surged by 430.0% to $66000.0 in 2014, then tumbled by 50.0% to $33000.0 in 2015, then sank by 103.03% to -$1000.0 in 2016.
- According to Business Quant data, Change in Receivables over the past three periods registered -$1000.0, $33000.0, and -$107000.0 for Q2 2016, Q4 2015, and Q3 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Xtl Biopharmaceuticals | 2.58 Bn | 2.58 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -1,000.00 |
| Jun 30, 2016 | -1,000.00 |
| Dec 31, 2015 | 33,000.00 |
| Dec 31, 2015 | 33,000.00 |
| Sep 30, 2015 | -107,000.00 |
| Sep 30, 2015 | -107,000.00 |
| Jun 30, 2015 | 52,000.00 |
| Jun 30, 2015 | 52,000.00 |
| Dec 31, 2014 | 66,000.00 |
| Dec 31, 2014 | 66,000.00 |
| Sep 30, 2014 | 10,000.00 |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Mar 31, 2014 | 11,000.00 |
| Mar 31, 2014 | 11,000.00 |
| Dec 31, 2013 | -20,000.00 |
| Dec 31, 2013 | -20,000.00 |
| Sep 30, 2013 | -9,000.00 |
| Sep 30, 2013 | -9,000.00 |